Drugs / PRO-167
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03520348 | Oct 2017 → May 2018 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-167 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03520348 ↗ |